Synerkine Pharma
PrivateLast Round
Series A
Extension
Oct 12, 2023
Total Funding Raised
$20.52M
Company Overview
Synerkine Pharma is a biopharmaceutical company that develops a class of biologics, called Synerkines, for the treatment of chronic pain.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Synerkine Pharma Comparables
Compare Synerkine Pharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ambros Therapeutics, Inc. | 75% | |
| Xalud Therapeutics | 70% | |
| BRC Therapeutics | 68% | |
Synerkine Pharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Oct 12, 2023 | ||||
| Series A Extension | Dec 16, 2021 | ||||
| Series A | Mar 25, 2019 |
Synerkine Pharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Thuja Capital | Series A Extension, Series A |
| InnovationQuarter | Series A Extension |
| Flerie AB | Series A Extension |
| Utrecht Holdings | Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 12, 2023
$13M round led by Flerie AB.
- Dec 16, 2021
$4M round led by Flerie AB
Synerkine Pharma Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Synerkine Pharma's valuation, stock price, and market status.